Financhill
Back

Encompass Health Quote, Financials, Valuation and Earnings

Encompass Health Price Quote

$83.21
-0.17 (-0.2%)
(Updated: May 1, 2024 at 12:00 PM ET)

Encompass Health Key Stats

Buy
73
Encompass Health (EHC) is a Buy

Day range:
$82.75 - $83.90
52-week range:
$57.55 - $85.84
Dividend yield:
0.72%
P/E ratio:
24.03
P/S ratio:
1.71
P/B ratio:
4.79%

Volume:
763.5K
Avg. volume:
761.3K
1-year change:
29.98%
Market cap:
$8.3B
Revenue:
$4.8B
EPS:
$3.7

How Much Does Encompass Health Make?

Is Encompass Health Growing As A Company?

  • What Is Encompass Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.13%
  • What Is Encompass Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.26%

Encompass Health Stock Price Performance

  • Did Encompass Health Stock Go Up Last Month?
    Encompass Health share price went up by 0.97% last month
  • Did EHC's Share Price Rise Over The Last Year?
    EHC share price rose by 29.98% over the past 1 year

What Is Encompass Health 52-Week High & Low?

Encompass Health Price To Free Cash Flow

Is It Risky To Buy Encompass Health?

  • How Much Debt Does Encompass Health Have?
    Total long term debt quarterly is $2.7B
  • How Much Cash Does Encompass Health Have?
    Cash and short term investments quarterly total is $134.4M
  • What Is Encompass Health’s Book Value Per Share?
    Book value per share is 17.39

Is Encompass Health Cash Flow Positive?

  • What Is EHC Cash Flow From Operations?
    Cash flow from operations (TTM) is $861.7M
  • What Is Encompass Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$179.8M
  • What Is Encompass Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$628.5M

Encompass Health Return On Invested Capital

  • Is Management Doing A Good Job?
    EHC return on invested capital is 7.69%
  • What Is Encompass Health Return On Assets?
    ROA measures how assets are converting to revenues and is 6.3%
  • What Is EHC Return On Equity?
    ROE is a measure of profitability and is 17.27%

Encompass Health Earnings Date & Stock Price

Encompass Health Competitors

  • Who Are Encompass Health's Competitors?
    Below is a list of companies who compete with Encompass Health or are related in some way:
    • American Oncology Network Inc (AONC)
    • DaVita Inc (DVA)
    • Pediatrix Medical Group Inc (MD)
    • The Oncology Institute Inc (TOI)
    • US Physical Therapy Inc (USPH)

Encompass Health Dividend Yield

Encompass Health Analyst Estimates

YoY Growth Past Surprise
EPS: 26.44% 19.6%
Revenue: 13.41% 3.41%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 94.91
Upside from Last Price: 13.83%

Major Shareholders

  • How many EHC shares are owned by institutional investors?
    158.3M EHC shares are owned by institutional investors
  • How many EHC shares are owned by insiders?
    5.7M EHC shares are owned by insiders